Core Competencies Advantage

917 Words4 Pages

SUSTAINABILITY OF THE COMPETITIVE ADVANTAGE ENJOYED BY OTHER PLAYERS IN THE INDUSTRY Organizations with core competencies enjoy global leadership. It represents the corporate philosophy; all business strategies revolve around the core competency. Organizations which believe in spending generously on research and development and the ones which experiment and investigate the processes can develop core competency. Core competencies lead to the development of core products. Core products are not directly sold to end users; rather, they are used to build a larger number of end-user products. For example, let’s take the example of Honda’a expertise in engines. Honda was able to exploit this core competency to develop a variety of quality products …show more content…

Next is the need to determine how to use the company’s core competencies to develop strategic responsiveness to maintain sustainability. High-performing companies develop new core competencies and expand their existing ones to enter new and future markets. At this level of functioning, the needs and wants of customers are recognized in new and future markets and the competencies necessary to meet those needs and wants are …show more content…

We believe the company has a narrow economic moat primarily due to its low-cost advantage, which includes low manufacturing, employee, and tax costs at its primary manufacturing base in India. Furthermore, in addition to its low-cost advantage, the firm’s vertically integrated operations through its API segment, and Sun’s focus on niche generic drug segments (including topicals and injectables), help the company earn profitability far above most of its peers. We think Sun’s expertise in relatively more complex generic pharmaceuticals will help sustain the company’s growth and profitability, thereby stabilizing the company’s economic moat. Most of Sun’s products are off-patent generic drugs that generally have numerous competitors and low-profitability. However, Sun earns industry leading profitability by combining its low-cost operations with unique drug categories within the generic space where greater product complexity produces more pricing power than typically seen with conventional generic

Open Document